Tumor lysis syndrome classification

Tumor lysis syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tumor lysis syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tumor lysis syndrome classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tumor lysis syndrome classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tumor lysis syndrome classification

CDC on Tumor lysis syndrome classification

Tumor lysis syndrome classification in the news

Blogs on Tumor lysis syndrome classification

Directions to Hospitals Treating Tumor lysis syndrome

Risk calculators and risk factors for Tumor lysis syndrome classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:  Mohamad Alkateb, MBBCh [2]

## Overview[edit | edit source]

Tumor lysis syndrome (TLS) may be classified according to the 1993 Hande-Garrow classification system into two groups: laboratory tumor lysis syndrome (LTLS) and clinical tumor lysis syndrome (CTLS).

## Classification[edit | edit source]

Tumor lysis syndrome may be classified according to the 1993 Hande-Garrow classification system into two groups:[1][2]

* Laboratory tumor lysis syndrome: patients have positive laboratory findings with no signs or symptoms
* Clinical tumor lysis syndrome: patients have life threatening medical signs and require urgent medical interventions

## References[edit | edit source]

1. ↑ Cairo MS, Bishop M (October 2004). "Tumour lysis syndrome: new therapeutic strategies and classification". Br. J. Haematol. 127 (1): 3–11. doi:10.1111/j.1365-2141.2004.05094.x. PMID 15384972.
2. ↑ Jeha S (October 2001). "Tumor lysis syndrome". Semin. Hematol. 38 (4 Suppl 10): 4–8. PMID 11694945.

Template:WH Template:WS